Scalable Synthesis of a Dual TLR7/8 Agonist via Highly Selective N 2-Alkylation of 1 H -Pyrazolo[4,3- d ]pyrimidine
Organic Letters · 2025
DOI: 10.1021/acs.orglett.5c04092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, 2025. Verfasst von Kai-Jiong Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Toll-Like Receptor 8, Pyrimidines, Pyrazoles. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
- Department of Process Research and Development, Changzhou SynTheAll Pharmaceutical Co., Ltd, Changzhou 213127, Jiangsu, China.
- Department of Process Research and Development, Merck & Co., Inc., West Point, Pennsylvania 19486, United States.
ORCID-Profile: Kai-Jiong Xiao
Zitieren
APA
Xiao, K. J., Xu, Y., Chen, L., Wu, Z., Fang, W., Miller, S. P., & Yin, J. (2025). Scalable Synthesis of a Dual TLR7/8 Agonist via Highly Selective N 2-Alkylation of 1 H -Pyrazolo[4,3- d ]pyrimidine. Organic Letters. https://doi.org/10.1021/acs.orglett.5c04092
Vancouver
Xiao KJ, Xu Y, Chen L, Wu Z, Fang W, Miller SP, et al. Scalable Synthesis of a Dual TLR7/8 Agonist via Highly Selective N 2-Alkylation of 1 H -Pyrazolo[4,3- d ]pyrimidine. Organic Letters. 2025. doi:10.1021/acs.orglett.5c04092
BibTeX
@article{Xiao2025,
author = {Xiao, Kai-Jiong and Xu, Yingju and Chen, Lu and Wu, Zheng and Fang, Wenzhi and Miller, Steven P and Yin, Jingjun},
title = {Scalable Synthesis of a Dual TLR7/8 Agonist via Highly Selective N 2-Alkylation of 1 H -Pyrazolo[4,3- d ]pyrimidine},
journal = {Organic Letters},
year = {2025},
doi = {10.1021/acs.orglett.5c04092}
}
EUVIMED